Malondialdehyde Serum Levels in Patients with Systemic Sclerosis Relate to Dyslipidemia and Low Ventricular Ejection Fraction.

Ibrahim-Achi, Zeina; Jorge-Pérez, Pablo; Abreu-González, Pedro; López-Mejías, Raquel; Martín-González, Candelaria; González-Gay, Miguel Á; Ferraz-Amaro, Iván

Ibrahim-Achi, Zeina; Jorge-Pérez, Pablo; Abreu-González, Pedro; López-Mejías, Raquel; Martín-González, Candelaria; González-Gay, Miguel Á; Ferraz-Amaro, Iván.

Affiliation

Ibrahim-Achi Z; Division of Angiology and Vascular Surgery, Hospital Universitario de Canarias, 38320 Tenerife, Spain.
Jorge-Pérez P; Division of Cardiology, Hospital Universitario de Canarias, 38320 Tenerife, Spain.
Abreu-González P; Unit of Physiology, Department of Basic Medical Sciences, University of La Laguna, 38200 Tenerife, Spain.
López-Mejías R; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Instituto de Investigación Marqués de Valdecilla, 39011 Santander, Spain.
Martín-González C; Department of Internal Medicine, University of La Laguna, 38200 Tenerife, Spain.
González-Gay MÁ; Division of Rheumatology, IIS-Fundación Jiménez Díaz, 28040 Madrid, Spain.
Ferraz-Amaro I; Department of Internal Medicine, University of La Laguna, 38200 Tenerife, Spain.

Antioxidants (Basel) ; 12(9)2023 Aug 25.

Article de En | MEDLINE | ID: mdl-37759971

Mots clés

malondialdehyde; systemic sclerosis

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Antioxidants (Basel) Année: 2023 Type de document: Article Pays d'affiliation: Espagne Pays de publication: Suisse

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google